Sanofi Detailed Consensus >> Business P&L
Consensus as of: 2026-08-31

KPI[EUR m]Q3 2025FY 2025Q3 2026 EFY 2026 EFY 2027 EFY 2028 EFY 2029 EFY 2030 EFY 2031 EFY 2032 E
Net salesNumber of Estimates1213131312121211
Net salesHighest13,77048,49051,63654,46957,04259,17861,27362,153
Net salesConsensus (Mean)12,43443,62613,17547,80850,85553,40855,78757,80756,74752,665
Net salesLowest12,84946,91749,52552,05353,47854,65052,38543,377
Other revenuesNumber of Estimates1213131312121211
Other revenuesHighest8343,4103,6513,8584,0114,1133,9973,513
Other revenuesConsensus (Mean)7363,0907363,0643,1223,1843,1673,2063,2263,165
Other revenuesLowest6172,6712,6482,6072,5652,5232,4812,440
Cost of salesNumber of Estimates1212121212121211
Cost of salesHighest-3,342-13,110-13,226-13,204-13,540-13,346-13,229-12,864
Cost of salesConsensus (Mean)-3,355-12,923-3,553-13,435-14,008-14,468-14,850-15,226-15,221-14,510
Cost of salesLowest-3,768-13,794-14,655-15,490-16,146-16,689-16,504-15,914
Gross ProfitNumber of Estimates1212121212121211
Gross ProfitHighest10,85238,12440,83243,51446,03147,80049,40549,756
Gross ProfitConsensus (Mean)9,81533,79310,35837,49140,04942,19744,10345,78744,75241,320
Gross ProfitLowest9,84336,70938,87440,38941,45742,35640,29432,150
- as % of net sales (gross margin)Number of Estimates1212121212121211
- as % of net sales (gross margin)Highest79.879.179.580.180.781.580.680.1
- as % of net sales (gross margin)Consensus (Mean)78.977.578.678.378.678.879.079.278.878.3
- as % of net sales (gross margin)Lowest76.677.477.377.277.277.276.974.1
Research and development expensesNumber of Estimates1213131312121211
Research and development expensesHighest-1,869-8,019-8,288-8,437-8,138-8,264-8,373-7,741
Research and development expensesConsensus (Mean)-1,834-7,842-2,033-8,318-8,584-8,786-8,976-9,225-9,233-9,092
Research and development expensesLowest-2,382-8,915-9,203-9,167-9,389-9,707-9,737-10,030
Selling and general expensesNumber of Estimates1213131312121211
Selling and general expensesHighest-2,349-9,774-10,162-10,575-10,757-10,809-10,474-9,957
Selling and general expensesConsensus (Mean)-2,291-9,543-2,517-10,110-10,520-10,844-11,114-11,394-11,328-11,161
Selling and general expensesLowest-2,802-10,561-10,875-11,206-11,548-11,892-11,897-11,904
Other current operating income/expenseNumber of Estimates1212121212121211
Other current operating income/expenseHighest-1,279-5,009-4,779-4,750-4,970-5,139-4,868-2,444
Other current operating income/expenseConsensus (Mean)-1,303-4,424-1,567-5,772-6,815-7,350-7,840-8,158-7,337-5,742
Other current operating income/expenseLowest-1,817-6,396-7,562-8,220-9,031-9,544-9,411-9,008
of which Amvuttra income Number of Estimates81010101010109
of which Amvuttra income Highest3591,2231,6492,0402,3782,6862,7922,544
of which Amvuttra income Consensus (Mean)--2801,0211,4001,6511,8882,1022,1341,913
of which Amvuttra income Lowest2218341,3011,4991,5881,6671,6031,500
(based on Amvuttra sales in USDm used for estimation)Number of Estimates67777777
(based on Amvuttra sales in USDm used for estimation)Highest1,2004,3855,7807,1718,3399,6049,80110,034
(based on Amvuttra sales in USDm used for estimation)Consensus (Mean)--1,1234,2595,4626,4917,3908,0307,8267,241
(based on Amvuttra sales in USDm used for estimation)Lowest1,0033,8965,1826,1056,4686,7915,7974,337
of which Regeneron alliance (profit) / loss sharingNumber of Estimates68888887
of which Regeneron alliance (profit) / loss sharingHighest-1,780-6,417-7,990-8,543-9,023-9,537-7,597-5,220
of which Regeneron alliance (profit) / loss sharingConsensus (Mean)---1,949-7,003-8,483-9,187-9,855-10,374-9,618-8,004
of which Regeneron alliance (profit) / loss sharingLowest-2,089-7,444-9,026-9,753-10,751-11,320-11,407-10,320
Share of profit/loss of associates and joint venturesNumber of Estimates1111111111111110
Share of profit/loss of associates and joint venturesHighest68203221237250275275275
Share of profit/loss of associates and joint venturesConsensus (Mean)6217949172185193200206208209
Share of profit/loss of associates and joint venturesLowest35148150150150150150164
Net income attributable to non-controlling interestsNumber of Estimates1212121212121211
Net income attributable to non-controlling interestsHighest-2-12000000
Net income attributable to non-controlling interestsConsensus (Mean)-4-14-5-16-15-15-14-14-14-13
Net income attributable to non-controlling interestsLowest-15-36-34-33-31-29-28-27
Business operating incomeNumber of Estimates1212121212121211
Business operating incomeHighest4,94013,68914,97116,22917,38418,72219,62119,807
Business operating incomeConsensus (Mean)4,44512,1494,27213,41814,29215,41516,32417,16617,01115,479
Business operating incomeLowest3,48513,03813,30913,79114,07814,58214,0288,519
- as % of net sales (operating margin)Number of Estimates1212121212121211
- as % of net sales (operating margin)Highest37.428.529.830.731.231.732.032.0
- as % of net sales (operating margin)Consensus (Mean)35.727.832.428.028.028.829.329.729.929.2
- as % of net sales (operating margin)Lowest27.127.426.426.526.326.726.819.6
Financial income & expenseNumber of Estimates1212121212121211
Financial income & expenseHighest-90-345-11196256426630856
Financial income & expenseConsensus (Mean)-64-262-123-432-386-289-172-4881218
Financial income & expenseLowest-210-602-580-538-480-393-303-222
- % tax rateNumber of Estimates1212121212121211
- % tax rateHighest-19.1-20.4-19.9-19.9-19.9-19.9-19.9-19.9
- % tax rateConsensus (Mean)-19.3-19.9-20.5-20.9-20.8-20.8-20.8-20.8-20.9-20.9
- % tax rateLowest-21.9-21.4-21.5-21.3-21.3-21.3-21.9-21.6
Business net incomeNumber of Estimates1212121212121211
Business net incomeHighest3,85410,55511,67212,65613,67214,87115,73216,045
Business net incomeConsensus (Mean)3,5479,5553,30710,29311,04312,01612,82713,59113,55912,448
Business net incomeLowest2,6729,99610,24410,68910,94911,38110,9776,658
- as % of net sales (net profit margin)Number of Estimates1212121212121211
- as % of net sales (net profit margin)Highest29.222.022.924.024.725.225.826.5
- as % of net sales (net profit margin)Consensus (Mean)28.521.925.121.521.722.423.023.523.923.5
- as % of net sales (net profit margin)Lowest20.820.920.320.520.520.821.015.4
Number of sharesNumber of Estimates1212121212121211
Number of sharesHighest1,2141,2021,2001,2011,2081,2141,2201,225
Number of sharesConsensus (Mean)1,2181,2201,1941,1961,1931,1891,1831,1761,1661,155
Number of sharesLowest1,1731,1741,1681,1511,1141,053972909
Business EPS (in EUR)Number of Estimates1212121212121211
Business EPS (in EUR)Highest3.238.869.7510.5911.8312.8013.4713.19
Business EPS (in EUR)Consensus (Mean)2.917.832.778.599.2510.1010.8411.5711.6610.84
Business EPS (in EUR)Lowest2.208.328.568.939.159.519.175.56
Dividend Per Share (in EUR)Number of Estimates-12121212121211
Dividend Per Share (in EUR)Highest-4.504.955.425.826.206.546.28
Dividend Per Share (in EUR)Consensus (Mean)-4.12-4.304.534.785.035.295.485.46
Dividend Per Share (in EUR)Lowest-4.114.234.364.494.624.704.70
Disclaimer

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.